291 related articles for article (PubMed ID: 27295402)
21. Blinded sample size re-estimation in crossover bioequivalence trials.
Golkowski D; Friede T; Kieser M
Pharm Stat; 2014; 13(3):157-62. PubMed ID: 24715672
[TBL] [Abstract][Full Text] [Related]
22. A SAS macro for sample size adjustment and randomization test for internal pilot study.
Wang S; Xia J; Yu L; Li C; Xu L
Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
[TBL] [Abstract][Full Text] [Related]
23. Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments.
Gera RG; Friede T
Biom J; 2023 Oct; 65(7):e2000326. PubMed ID: 37309256
[TBL] [Abstract][Full Text] [Related]
24. Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trials.
Friede T; Schmidli H
Methods Inf Med; 2010; 49(6):618-24. PubMed ID: 20686735
[TBL] [Abstract][Full Text] [Related]
25. Increasing the sample size when the unblinded interim result is promising.
Chen YH; DeMets DL; Lan KK
Stat Med; 2004 Apr; 23(7):1023-38. PubMed ID: 15057876
[TBL] [Abstract][Full Text] [Related]
26. Sample size determination in group-sequential clinical trials with two co-primary endpoints.
Asakura K; Hamasaki T; Sugimoto T; Hayashi K; Evans SR; Sozu T
Stat Med; 2014 Jul; 33(17):2897-913. PubMed ID: 24676799
[TBL] [Abstract][Full Text] [Related]
27. Extension of a conditional performance score for sample size recalculation rules to the setting of binary endpoints.
Bokelmann B; Rauch G; Meis J; Kieser M; Herrmann C
BMC Med Res Methodol; 2024 Jan; 24(1):15. PubMed ID: 38243169
[TBL] [Abstract][Full Text] [Related]
28. Blinded sample size re-estimation for recurrent event data with time trends.
Schneider S; Schmidli H; Friede T
Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
[TBL] [Abstract][Full Text] [Related]
29. Performance of adaptive designs for single-armed phase II oncology trials.
Kieser M; Englert S
J Biopharm Stat; 2015; 25(3):602-15. PubMed ID: 24905363
[TBL] [Abstract][Full Text] [Related]
30. Multiplicity adjustment for composite binary endpoints.
Rauch G; Kieser M
Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
[TBL] [Abstract][Full Text] [Related]
31. Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels.
Żebrowska M; Posch M; Magirr D
Stat Med; 2016 May; 35(12):1972-84. PubMed ID: 26694878
[TBL] [Abstract][Full Text] [Related]
32. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
Kieser M; Friede T
Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
[TBL] [Abstract][Full Text] [Related]
33. Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial.
Xiong C; Yu K; Gao F; Yan Y; Zhang Z
Clin Trials; 2005; 2(5):387-93. PubMed ID: 16317808
[TBL] [Abstract][Full Text] [Related]
34. Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.
Rauch G; Beyersmann J
Stat Med; 2013 Sep; 32(21):3595-608. PubMed ID: 23553898
[TBL] [Abstract][Full Text] [Related]
35. Testing multiple primary endpoints in clinical trials with sample size adaptation.
Liu Y; Hu M
Pharm Stat; 2016; 15(1):37-45. PubMed ID: 26607410
[TBL] [Abstract][Full Text] [Related]
36. Internal pilot design for balanced repeated measures.
Zhang X; Muller KE; Goodenow MM; Chi YY
Stat Med; 2018 Feb; 37(3):375-389. PubMed ID: 29164637
[TBL] [Abstract][Full Text] [Related]
37. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
Chen YH; Li C; Lan KK
Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
[TBL] [Abstract][Full Text] [Related]
38. Blinded sample size recalculation in adaptive enrichment designs.
Placzek M; Friede T
Biom J; 2023 Feb; 65(2):e2000345. PubMed ID: 35983952
[TBL] [Abstract][Full Text] [Related]
39. Sample size adaptation in fixed-dose combination drug trial.
James Hung HM; Wang SJ
J Biopharm Stat; 2012; 22(4):679-86. PubMed ID: 22651108
[TBL] [Abstract][Full Text] [Related]
40. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
Kieser M; Friede T
Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
